Mammography's Business Outlook - Is the Current U.S. Benchmark Sustainable?

This white paper explores the current clinical, business and regulatory trends in mammography, specifically addressing whether we have plateaued in striving for even earlier detection and the associated 98% survival rate for early stage breast cancer.